 |
EnergyMD PodcastAuthor: Evan H. Hirsch, MD
Hosted by the best selling author & founder of the EnergyMD Method, Evan H. Hirsch, MD, the EnergyMD Podcast introduces thought leaders like Alex Howard, Dr. Amie Hornaman, Jodi Cohen, Evan Brand, Dr. Al Danenberg, Dr. Joan Rosenberg, Debora Wayne, Dr. Debi Silber, Dr. Madiha Saeed, Dr. Kasia Kines, Dr. Darin Ingels, JJ Virgin and others to help all those who struggle with low energy, fatigue and Long COVID, and are looking for practical and natural solutions that work. Learn more at https://www.energymdmethod.com Language: en Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Can Paxlovid Help People with Long COVID? with Evan H. Hirsch, MD
Episode 228
Wednesday, 9 September, 2026
Paxlovid helped a lot of people get over COVID faster. But what about the people who never got better? A large NIH-funded trial put that question to the test in almost 1,000 people, and the answer was no. The 89% reduction that made Paxlovid famous came out of a narrow, high-risk group back in 2021, during the Delta wave. That was a different question, in a different group, at a different point in the pandemic. Evan H. Hirsch, MD, breaks down what the RECOVER-VITAL trial actually found after six months, why trials at Yale and Stanford landed in the same place, and what the drug was designed to do from the start. He also gets into what else is keeping you sick: the spike protein appears to wake up viruses that have been dormant inside you for years, and he shares how a client who took Paxlovid twice only got better once all of the Toxic 5 were addressed. In this episode, you'll learn: What Paxlovid was actually approved for, and why the famous 89% reduction in hospitalizations came out of a narrow, high-risk group during the 2021 Delta wave What the NIH-funded RECOVER-VITAL trial found when almost 1,000 people took extended Paxlovid for six months, and why trials at Yale and Stanford found the same thing Why the drug is safe to take for that long but still cannot resolve Long COVID on its own How the spike protein appears to wake up viruses like Epstein-Barr and HHV6 that over 90% of us already carry, and why a new trial at Mount Sinai is stacking antivirals because of it What the Toxic 5 are, and how a client who took Paxlovid twice recovered only after all five root causes were addressed How a client recovered by addressing all five root causes together, not just the reactivated virus driving her brain fog Discover your fatigue score and the root causes keeping you stuck: https://myfatiguescore.com Free Fatigue Masterclass: https://fixyourfatigue.com See real results: https://energymdmethod.com/results Chapters: 00:00 - Introduction 00:38 - What Paxlovid Is and What It Was Made For 01:53 - Can Paxlovid Help the Chronic Version? 02:19 - What the RECOVER-VITAL Trial Found 03:13 - Why One Antiviral Was Never Enough 04:24 - The Viruses the Spike Protein Wakes Up 05:39 - Case Study: A Client's Recovery 06:43 - Where That Leaves Paxlovid Subscribe to the EnergyMD Podcast for weekly conversations with leading experts on resolving ME/CFS and Long COVID by addressing the real root causes. . For more information about Evan and his program, Click Here. Prefer to watch on Youtube? Click Here. Please note that any information in this episode is for educational purposes only and does not constitute medical advice.
